MRSH

Business profile & competitive position

Marsh & McLennan Companies, Inc. (MRSH) sits in the Financial Services sector, specifically the Insurance - Brokers industry. It is a global professional-services firm organized around risk, reinsurance and capital, people and investments, and management consulting. According to its most recent annual filing, the company serves clients in 130 countries, generates roughly $27 billion in annual revenue, and employs more than 95,000 colleagues. Operations are split into two main segments: Risk and Insurance Services—led by Marsh Risk and Guy Carpenter—and Consulting, which houses Mercer plus Marsh Management Consulting.

The numbers in the current snapshot suggest a business model built on scale and recurring advisory relationships. The net margin is 14.2%, and return on equity is 26.5%. An ROE of 26.5% on a net margin in the low teens is consistent with an asset-light, human-capital-driven franchise where revenue comes from fees, commissions and retainers rather than heavy balance-sheet intensity. The beta is 0.58, meaning the stock has historically moved less than half as much as the broader market, which fits an oligopolistic, non-discretionary-risk-advisory business. While those figures do not prove a moat by themselves, they are the financial signature of a broker-consultant with pricing power, geographic diversification and long-duration client contracts.

Financial posture

Marsh & McLennan currently carries a market capitalization of $90.6 billion and trades at a P/E ratio of 23.1. Against the 14.2% net margin and 26.5% ROE, that multiple reads like a quality premium rather than a deep-value valuation. The company earns above-average returns on equity, so the market is pricing it as a compounder rather than a distressed or cyclical name. The beta of 0.58 reinforces that view: low systematic risk supports a higher terminal valuation, but it also means the stock rarely looks “cheap” on a P/E basis unless the broader market sells off.

The current price is $189.8, with the 50-day exponential moving average at $184.23 and the relative strength index (RSI) at 52.3. Those technical readings are neutral, sitting close to fair-trend and mid-range momentum readings. The snapshot does not provide a debt figure, so we limit leverage commentary to what is observable: the business generates enough profitability that balance-sheet risk is not the first concern implied by the data.

Strategic priorities & outlook

The company’s most recent 10-K outlines several near-term operational priorities. One is brand architecture: it plans to roll out an updated Marsh corporate brand and align Marsh Risk and Marsh Management Consulting under their new names, while Mercer and Guy Carpenter will keep their current brands for the time being. The goal is to simplify the parent-company story without disrupting established sub-brands that hold their own client recognition.

A second priority is extracting value from the Thrive program, which focuses on brand strategy, delivering greater value to clients, accelerating growth and improving efficiency. Third, management intends to keep building the Marsh McLennan Agency (MMA) platform, which has acquired more than 135 agencies since 2009, and to broaden its solutions across business insurance, employee health and benefits, retirement, wealth management and private-client advisory. The fourth priority is human capital: the firm is scaling colleague skills through AI Academies and its leadership Mindset Academy, with more than 46,000 AI Academy credentials earned since the August 2024 launch.

Operationally, the 2025 revenue mix was approximately 64% Risk and Insurance Services and 36% Consulting. Marsh Risk alone contributed about 54% of total revenue, Guy Carpenter about 10%, and the Consulting segment—comprising Mercer and Marsh Management Consulting—supplied the remaining 36%. Mercer oversaw roughly $692 billion in assets worldwide as of December 31, 2025. That revenue concentration means underwriting market conditions and employer benefit-spending decisions remain material drivers, while the consulting arm adds a counter-cyclical advisory revenue stream tied to workforce and investment decisions.

Macro & geopolitical exposure

As an insurance broker and professional-services conglomerate, Marsh & McLennan is exposed to the commercial insurance pricing cycle, interest rates, catastrophe activity and regulatory changes rather than to commodity prices directly. When property-casualty markets harden, brokers typically collect higher commissions in absolute dollars; when markets soften, revenue growth pressure follows. Low interest rates can compress insurer investment income and alter capital availability, while natural catastrophe losses can spike pricing and demand for risk advisory services.

Currency is another real exposure: roughly 130 countries contribute revenue, so a stronger U.S. dollar translates non-dollar earnings lower on repatriation. Regulatory risk includes insurance distribution rules, fiduciary standards for retirement advice through Mercer, and data-privacy rules governing client information. Geopolitical tensions and trade-policy shifts can increase corporate demand for political-risk, supply-chain and cyber insurance, benefiting Marsh’s advisory franchise, but they can also dampen cross-border mergers, IPO pipelines and management-consulting backlogs. Labor-market tightness affects Mercer’s health, wealth and career advisory business, and broad economic growth drives both commercial insurance placements and consulting project flow.

Recent developments

The most recent headlines give a sense of how the company is showing up in the market. On August 31, 2026, both GuruFocus and BusinessWire reported that U.S. employers are sticking with moderate pay increases for 2027, according to Marsh’s Mercer QuickPulse® Survey. The data point is relevant to the Mercer consulting franchise and suggests employer compensation planning remains cautious, which could influence consulting demand around workforce strategy.

On August 30, 2026, DefenseWorld.net reported that Connor Clark & Lunn Investment Management Ltd. purchased 9,305 shares of MRSH. The size of the position is modest relative to a $90.6 billion market cap, so it reads more as a routine institutional allocation update than a catalyst, but it does show continuing institutional interest.

Earlier, on August 27, 2026, GuruFocus noted that Marsh’s Oliver Wyman joined Anthropic’s Claude Partner Network. That headline dovetails with the 10-K’s emphasis on AI upskilling and signals that the consulting side is embedding generative-AI partnerships into its advisory toolkit, potentially affecting the economics of management-consulting engagements over time.

Earnings behavior & post-earnings drift

Marsh & McLennan has an unusually strong earnings track record over the last eight reported quarters: it beat consensus EPS in 8 out of 8 quarters, for a 100% beat rate, with an average earnings surprise of 3.4%. Despite that consistency, the average five-day price move after earnings across those quarters was just 0.45%, classified as “flat.” That pattern—reliable upside to estimates but muted post-report drift—suggests the market already prices in a good outcome and tends to digest beats without a sustained directional move.

The last four reports illustrate the point. On July 21, 2026, MRSH reported EPS of $2.96 against a $2.88 estimate, a 2.8% surprise, but the stock fell 3.08% the next day before recovering to a 5.84% gain over the following five sessions. On April 16, 2026, EPS of $3.29 beat the $3.22 estimate by 2.2%; the stock dropped 3.71% the next day and was down 4.69% over the next five sessions. On January 29, 2026, a much larger 7.6% beat ($2.12 actual vs. $1.97 estimate) produced only a 0.14% next-day move and a 0.22% five-day decline. And on October 16, 2025, EPS of $1.85 beat the $1.78 estimate by 3.9%, with the stock rising 1.67% the next day and 0.86% over the following five days.

The next scheduled report is October 15, 2026, before the market open, with a consensus EPS estimate of $1.96. Because MRSH has beaten estimates in every one of the prior eight quarters, the market’s real expectation may be modestly above that printed consensus; nevertheless, the flat average drift shows that beating is not, by itself, a reliable bullish catalyst for the shares.

For a deeper dive into how institutional analysts are weighing these fundamentals, valuation, and earnings dynamics, look at the full institutional verdict on MRSH.